These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38712757)

  • 1. Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase.
    Craven TW; Nolan MD; Bailey J; Olatunji S; Bann SJ; Bowen K; Ostrovitsa N; Da Costa TM; Ballantine RD; Weichert D; Levine PM; Stewart LJ; Bhardwaj G; Geoghegan JA; Cochrane SA; Scanlan EM; Caffrey M; Baker D
    ACS Chem Biol; 2024 May; 19(5):1125-1130. PubMed ID: 38712757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of globomycin analogs as novel gram-negative antibiotics.
    Garland K; Pantua H; Braun MG; Burdick DJ; Castanedo GM; Chen YC; Cheng YX; Cheong J; Daniels B; Deshmukh G; Fu Y; Gibbons P; Gloor SL; Hua R; Labadie S; Liu X; Pastor R; Stivala C; Xu M; Xu Y; Zheng H; Kapadia SB; Hanan EJ
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127419. PubMed ID: 32768648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
    Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in
    Huang KJ; Pantua H; Diao J; Skippington E; Volny M; Sandoval W; Tiku V; Peng Y; Sagolla M; Yan D; Kang J; Katakam AK; Michaelian N; Reichelt M; Tan MW; Austin CD; Xu M; Hanan E; Kapadia SB
    Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2123117119. PubMed ID: 36099298
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity.
    Bionda N; Stawikowski M; Stawikowska R; Cudic M; López-Vallejo F; Treitl D; Medina-Franco J; Cudic P
    ChemMedChem; 2012 May; 7(5):871-82. PubMed ID: 22392790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in macrocyclic peptide-based antibiotics.
    Luther A; Bisang C; Obrecht D
    Bioorg Med Chem; 2018 Jun; 26(10):2850-2858. PubMed ID: 28886999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin.
    Vogeley L; El Arnaout T; Bailey J; Stansfeld PJ; Boland C; Caffrey M
    Science; 2016 Feb; 351(6275):876-80. PubMed ID: 26912896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.
    Riahifard N; Mozaffari S; Aldakhil T; Nunez F; Alshammari Q; Alshammari S; Yamaki J; Parang K; Tiwari RK
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimicrobial activity of novel globomycin analogues.
    Kiho T; Nakayama M; Yasuda K; Miyakoshi S; Inukai M; Kogen H
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2315-8. PubMed ID: 12824025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depsipeptide synthesis.
    Stawikowski M; Cudic P
    Methods Mol Biol; 2007; 386():321-39. PubMed ID: 18604953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LspA-independent action of globomycin on Mycobacterium tuberculosis.
    Banaiee N; Jacobs WR; Ernst JD
    J Antimicrob Chemother; 2007 Aug; 60(2):414-6. PubMed ID: 17579235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's Lipoprotein.
    Diao J; Komura R; Sano T; Pantua H; Storek KM; Inaba H; Ogawa H; Noland CL; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Volny M; Liu P; Nickerson NN; Sandoval W; Austin CD; Murray J; Rutherford ST; Reichelt M; Xu Y; Xu M; Yanagida H; Nishikawa J; Reid PC; Cunningham CN; Kapadia SB
    J Bacteriol; 2021 Jun; 203(13):e0014921. PubMed ID: 33875545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of globomycin analogues as antibiotics.
    Kiho T; Nakayama M; Yasuda K; Miyakoshi S; Inukai M; Kogen H
    Bioorg Med Chem; 2004 Jan; 12(2):337-61. PubMed ID: 14723954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics.
    Chen L; Yuan Y; Helm JS; Hu Y; Rew Y; Shin D; Boger DL; Walker S
    J Am Chem Soc; 2004 Jun; 126(24):7462-3. PubMed ID: 15198592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of new cyclic analogues of the antimicrobial lipopeptide tridecaptin A
    Ballantine RD; Li YX; Qian PY; Cochrane SA
    Chem Commun (Camb); 2018 Sep; 54(75):10634-10637. PubMed ID: 30179243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis and examination of three key analogues of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity.
    Rew Y; Shin D; Hwang I; Boger DL
    J Am Chem Soc; 2004 Feb; 126(4):1041-3. PubMed ID: 14746470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad-spectrum antimicrobial activity of secondary metabolites produced by Serratia marcescens strains.
    Clements T; Ndlovu T; Khan W
    Microbiol Res; 2019 Dec; 229():126329. PubMed ID: 31518853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Structure-Activity Relationship Study, Bioactivity, and Nephrotoxicity Evaluation of the Proposed Structure of the Cyclic Lipodepsipeptide Brevicidine B.
    Palpal-Latoc D; Horsfall AJ; Cameron AJ; Campbell G; Ferguson SA; Cook GM; Sander V; Davidson AJ; Harris PWR; Brimble MA
    J Nat Prod; 2024 Apr; 87(4):764-773. PubMed ID: 38423998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.